Science Stories
Discover the Weizmann Institute of Science
Book your VIP visit today
Jill and Joel Reitman, and son Richard (center) visited the Weizmann Institute of Science in November

Meet scientific leaders who are making a global impact, explore the breathtaking campus and laboratories, learn about the innovative research and, of course, play in our Clore Garden of Science. Read what a recent visitor had to say.

“This past November I was fortunate enough to travel to Israel and tour the Weizmann institute with my parents. With our guide Shira, we visited some of the campus highlights including the visitor’s centre, remarkable laboratories and even the historic residence of Chaim Weizmann. The visit not only met, but it exceeded my expectations. What stood out most to me was not the state of the art buildings nor the beautiful gardens, but the egalitarian environment of scientists from diverse religions, nationalities, and ethnicities collaborating together to produce research on which the world will rely.

Among the scientists with whom we met was Michal Schwartz, one of the Institute’s leading researchers on Alzheimer’s disease. Having had a grandfather who suffered from this disease for years before he passed away, this meeting really hit close to home for my parents and me. Her innovative research on the relationship between the brain and the immune system as a means to target the disease truly gave us hope that a cure or at least a prevention is within reach. Professor Schwartz’s work at the institute is just one example of how Weizmann, and the state of Israel, is advancing the world.” —Richard Reitman

Let us plan a memorable visit to the Weizmann Institute for you. Contact info@weizmann.ca
or 1-800-387-3894.

Related Stories
Science Stories
Discovering a new kind of sensing complex could help develop treatments for inflammatory diseases
Science Stories
Wasting syndrome – a deadly cancer side-effect – might be diagnosed and treated early on, according to a new study
Science Stories
Focusing on the ups and downs of multiple sclerosis, Weizmann Institute researchers discover a major player in its remission